Kestra Medical Technologies (KMTS) Non-Current Debt (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Non-Current Debt data on file, last reported at $42.3 million in Q1 2026.

• Quarterly Non-Current Debt fell 3.4% year-over-year to $42.3 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $42.3 million (down 3.4% YoY) and the FY2025 annual result came in at $41.1 million, down 3.38% from the prior year.
• Non-Current Debt advanced to $42.3 million in Q1 2026 per KMTS's latest filing, from $41.9 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $43.7 million in Q1 2025 and bottomed at $41.1 million in Q2 2025.
• The 3-year median for Non-Current Debt is $42.1 million (2025), against an average of $42.2 million.
• The widest annual swing landed in 2025, when Non-Current Debt retreated 3.38%; it then slipped 3.4% in 2026.
• Tracing KMTS's Non-Current Debt over 3 years: stood at $42.5 million in 2024, then decreased by 1.56% to $41.9 million in 2025, then grew by 0.93% to $42.3 million in 2026.
• Per Business Quant, the three latest KMTS Non-Current Debt figures stand at $42.3 million (Q1 2026), $41.9 million (Q4 2025), and $41.5 million (Q3 2025).

Peer Comparison